Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: Potential prodrugs of (R)- and (S)-nordeprenyl

Journal of Medicinal Chemistry

Volumn 39, Issue 24, 1996, Pages 4756-4761

  Flaherty, Patrick ^a   Castagnoli, Kay ^a   Wang, You Xiong ^a   Castagnoli Jr , Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CARBAMIC ACID DERIVATIVE; MONOAMINE OXIDASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PARKINSON DISEASE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CARBAMATES; ENZYME INHIBITORS; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED STRAINS; MITOCHONDRIA; MOLECULAR CONFORMATION; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLACENTA; PRODRUGS; PYRIDINES; SUBSTRATE SPECIFICITY;

EID: 0030449506     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960477e     Document Type: Article

References (22)

1. Chiba, K.; Trevor, A. J.; Castagnoli, N., Jr. Metabolism of the Neurotoxic Tertiary Amine MPTP by Brain Monoamine Oxidase. Biochem. Biophys. Res. Commun. 1984, 120, 574-578.
2. Salach, J. I.; Singer, T. P.; Castagnoli, N., Jr.; Trevor, A. Oxidation of the Neurotoxic Amine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), by MAO A and B and Suicide Inactivation of the Enzymes by MPTP. Biochem. Biophys. Res. Commun. 1984, 125, 831-835.
3. Zhao, Z.; Dalvie, D.; Naiman, N.; Castagnoli, K.; Castagnoli, N., Jr. Design, Synthesis, and Biological Evaluation of Novel 4-Substituted 1-Methyl-1,2,3,6-tetrahydropyridine Analogs of MPTP. J. Med. Chem. 1992, 35, 4473-4478.
4. Wang, Y.-X.; Castagnoli, N., Jr. Studies on the Monoamine Oxidase (MAO)-catalyzed Oxidation of Phenyl-substituted 1-Methyl-4-phenoxy-1,2,3,6-tetrahydropyridine Derivatives: Factors Contributing to MAO-A and MAO-B Selectivity. J. Med. Chem. 1995, 38, 1904-1910.
5. See Methods in Enzymology (1985, Part A 112, pp 309-396) for a thorough review of prodrug theory and design.
6. Berry, M. D.; Juorio, A. V.; Paterson, I. A. The Functional Role of Monoamine Oxidases A and B in the Mammalian Central Nervous System. Prog. Neurobiol. 1994, 42, 375-391.
7. Simpkins, J. W.; Bodor, N. The Brain-targeted Delivery of Dopamine Using a Redox-based Chemical Delivery System. Adv. Drug Delivery Rev. 1994, 14, 243-249.
8. Kalgutkar, A.; Castagnoli, K.; Hall, A.; Castagnoli, N., Jr. Novel 4-(Aryloxy)tetrahydropyridine Analogs of MPTP as Monoamine Oxidase A & B Substrates. J. Med. Chem. 1994, 37, 944-949.
9. Calne, D. B. Treatment of Parkinson's Disease. N. Engl. J. Med. 1993, 14, 1021-1027.
10. Borbe, H. O.; Niebch, G.; Nickel, B. Kinetic Evaluation of MAO-B Activity Following Oral Administration of Selegiline and Desmethyl-selegiline in the Rat. J. Neural Transm. Suppl. 1990, 32, 131-137.
11. Calne, D. B. Selegiline in Parkinson's Disease - No neuroprotective effect: Increased Mortality. Br. Med. J. 1995, 311, 1583-1584.
12. MacGregor, K. R.; Fowler, J. S.; Wolf, A. F. Synthesis of Suicide Inhibitors of Monoamine Oxidase: Carbon-11 Labeled Clorgyline, L-Deprenyl and D-Deprenyl. J. Labelled Compd. Radiopharm. 1988, 25, 1-9.
13. Clark, J. B.; Nicklas, W. J. The Metabolism of Rat Brain Mitochondria. Preparation and Characterization. J. Biol. Chem. 1970, 245, 4724-4731.
14. Hall, T. R.; Yurgens, P. B.; Figueroa, H. R.; Uruena, G.; Olcese, J. M.; Newton, D. K.; Vorwald, S. R. Monoamine Oxidase Types A and B in the Vertebrate Brain. Commun. Biochem. Physiol. C 1982, 1, 107-110.
15. Yu, P. H.; Davis, B. A.; Boulton, A. A. Aliphatic Propargylamines: Potent, Selective, Irreversible Monoamine Oxidase B Inhibitors. J. Med. Chem. 1992, 20, 3705-3713.
16. Tipton, K. F.; Youdim, M. B. H. The Assay of Monoamine Oxidase Activity. Methods Biogenic Amine Res. 1983, 20, 441-465.
17. Bai, H. Synthetic and Metabolic Studies on 1-Methyl-4-(1-methylpyrrol-2-yl)-1,2,3,6-tetrahydropyridme, a Neurotoxic Analog of the Parkinsonian Inducing Agent MPTP. M.S. Thesis, VPI&SU, Blacksburg, VA, 1991.
18. Yu, P. H. Monoamine Oxidase. In Neuromethods 5; Neurotransmitter Enzymes; Boulton, A. A., Baker, G. B., Yu, P. H., Eds.; Humana Press: Clifton, NJ, 1986; pp 235-272.
19. Youngster, S. K.; McKeown, K. A.; Jin, Y. Z.; Ramsay, R. R.; Heikkila, R. E.; Singer, T. P. Oxidation of Analogs of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Monoamine Oxidases A and B and the Inhibition of Monoamine Oxidases by the Oxidation Products. J. Neurochem. 1989, 53, 1837-1842.
20. Salach, J. I. Preparation of Monoamine Oxidase from Beef Liver Mitochondria. Methods Enzymol. 1978, 53, 495-459.
21. Rimoldi, J. M.; Wang, Y.-X.; Nimkar, S. K.; Kuttab, S. H.; Anderson, A. H.; Burch, H.; Castagnoli, N., Jr. Probing the Mechanism of Bioactivation of MPTP Type Analogs by Monoamine Oxidase B: Structure-Activity Studies on Substituted 4-Phenoxy-, 4-Phenyl-, and 4-Thiophenoxy-1-cyclopropyl-1,2,3,6-tetrahydropyridines. Chem. Res. Toxicol. 1995, 8, 703-710.
22. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-dye Binding. Anal. Biochem. 1976, 72, 247-254.